SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039394
Filing Date
2023-08-08
Accepted
2023-08-08 08:20:55
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-20230630.htm   iXBRL 10-Q 2139105
2 EX-31.1 cogt-ex31_1.htm EX-31.1 16912
3 EX-31.2 cogt-ex31_2.htm EX-31.2 16900
4 EX-32.1 cogt-ex32_1.htm EX-32.1 11329
5 EX-32.2 cogt-ex32_2.htm EX-32.2 11304
6 GRAPHIC img157444438_0.jpg GRAPHIC 67288
  Complete submission text file 0000950170-23-039394.txt   7091526

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cogt-20230630_def.xml EX-101.DEF 160961
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cogt-20230630_cal.xml EX-101.CAL 36895
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cogt-20230630_pre.xml EX-101.PRE 250352
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cogt-20230630.xsd EX-101.SCH 38587
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cogt-20230630_lab.xml EX-101.LAB 329931
49 EXTRACTED XBRL INSTANCE DOCUMENT cogt-20230630_htm.xml XML 1212769
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 231149465
SIC: 2834 Pharmaceutical Preparations